English 
Chinese 
Russian 
French Blog
How Much Does Stem Cell Therapy Cost in 2026? A Patient’s Realistic Guide
Stem cell therapy prices range from $2,000 to $100,000 depending on where you go. Here’s what actually drives the cost, what’s included, and how Thailand compares to the US, Australia, and Europe in 2026.
Jun 25, 2026
MSC Therapy for Inflammatory Bowel Disease: Crohn’s and Ulcerative Colitis in 2026
MSC therapy is offering new hope for IBD patients who don’t respond to conventional biologics. Here’s what the 2026 clinical data shows.
Jun 24, 2026
Stem Cell Therapy for Tendon and Ligament Injuries: Beyond PRP
PRP has its limits. For serious tendon and ligament injuries, stem cells are showing results PRP cannot match.
Jun 21, 2026
Senolytic MSC Therapy: Why Clearing Aged Cells First May Unlock Stem Cell Potential
A June 2026 study shows that senolytic preconditioning dramatically improves MSC efficacy by removing the SASP factors that suppress tissue repair. Plus: AAT-MSCs reverse diabetes via immune reprogramming, and a phase II…
Jun 20, 2026
MSC Therapy for Lupus Nephritis: 120-Patient Study Shows 57% Renal Response at 12 Months
A 2026 real-world study followed 120 refractory lupus nephritis patients treated with UC-MSCs. Cumulative renal response reached 56.7% at 12 months with low relapse rates and zero severe adverse events. Here’s what clini…
Jun 20, 2026
Stem Cell Therapy for Sports Injuries: What Weekend Warriors Need to Know
A 36-month clinical trial showed zero adverse events and 57% pain reduction when stem cells were injected into torn rotator cuffs. Here’s what weekend warriors and recreational athletes need to know about MSC therapy for…
Jun 19, 2026
Intravenous UC-MSCs for Ischemic Stroke: What the MERIT Phase 1 Trial Tells Us
The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.
Jun 19, 2026
MSC Therapy for Graft-versus-Host Disease: What 15 RCTs and a Biomarker-Guided Trial Tell Us
A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be nex…
Jun 8, 2026
What Happens to Your Stem Cells as You Age? And What You Can Do About It
Your body’s stem cell population drops dramatically after 40. Here’s what the science says about why we age — and how regenerative medicine is fighting back.
Jun 3, 2026
Stem Cells and Your Gut Microbiome: The Hidden Connection That Changes Everything
Your gut bacteria directly control how well your stem cells work. Here’s what every patient should know before treatment.
Jun 1, 2026
MSC Immunomodulation in Autoimmune Disease: Mechanisms, Clinical Evidence, and Therapeutic Windows
A technical deep dive into MSC immunomodulation for autoimmune disease: Treg induction, macrophage polarization, and clinical evidence from the SMART-MS trial.
May 29, 2026
CRISPR-Edited Mesenchymal Stem Cells: Engineering the Next Generation of Precision Cell Therapies
A New Chapter in Therapeutic Cell Engineering Mesenchymal stem cells — or more precisely, mesenchymal stromal cells — have occupied a unique niche in translational medicine for the better part of two decades. Their capac…
May 27, 2026
Page 3 of 6 — 68 posts